Written Question·Department of Health and Social Care·UIN 30537

Givinostat

Tabled: 10 February 2025
Answered: 25 February 2025
Named Day

Question

Perran Moon

LabourCamborne and Redruth

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of approving Givinostat for use to treat Duchenne Muscular Dystrophy in (a) Royal Cornwall Hospital Trust and (b) other NHS trusts.

Answer

Karin Smyth
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS independently based on an assessment of their costs and benefits. Th...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 30537) →